Como medir (o no medir) la adhesión en el tratamiento de erradicación

Abstract

This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients' reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients' perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients' normal behaviour.

Assessment of medication adherence among Lebanese adult patients with non-communicable diseases during COVID-19 lockdown: a cross-sectional study

“…In our study, patients with peptic ulcer disease had poor medication adherence, in agreement with data from previous studies (22). A possible explanation could be the metallic taste of medications used to eradicate Helicobacter pylori infection, as reported in previous research (23). Another reason could be the frequency of drug administration, the number of pills administered, and the complexity of eradication regimens, explaining the inverse relationship between the number of doses and adherence (24).…”

Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection

“…Patients with poor medication compliance is another key influencing factor of H. pylori treatment failure (Jaka et al, 2019; Lan et al, 2022; Osipenko et al, 2014; Shawky et al, 2022). Surprisingly, a growing body of recent studies suggested that pharmacists' participation in the process of H. pylori treatment could not only increase patients' medication compliance, but also reduce the treatment costs and improve clinical outcomes for patients (Al‐Eidan et al, 2002; Martins et al, 2006; Seko et al, 2019; Sun et al, 2020). Pharmacists should actively participate in the management practice of H. pylori eradication therapy, and provide individualized medication education to patients in hospitals or at home, so as to give full play to the social value of pharmacists (L. C. Li, Chen, et al, 2021; L. C. Li, Han, et al, 2021).…”

“…pylori patients' perceived health status by using electronic recording devices (Martins et al, 2006). A hospital in Japan investigated 452 patients infected with H. pylori who were managed by pharmacists from January 2015 to December 2017, and found that the medication guidance provided by pharmacists could improve the quality of life and H. pylori eradication rate (91.4%) though the pharmacists incurred additional labor costs (Seko et al, 2019).…”

“…Under the professional guidance of Chinese pharmacists, the eradication rate of H. pylori (92.5%), the proportion of correct medication (95%), the number of missed and stopped medication (5%), and the satisfaction of treatment (98.75%) were significantly improved (Sun et al, 2020). In Portugal, pharmacists could improve H. pylori patients' perceived health status by using electronic recording devices (Martins et al, 2006). A hospital in Japan investigated 452 patients infected with H. pylori who were managed by pharmacists from January 2015 to December 2017, and found that the medication guidance provided by pharmacists could improve the quality of life and H. pylori eradication rate (91.4%) though the pharmacists incurred additional labor costs (Seko et al, 2019).…”

“…Combined with the emerging research, pharmacists' participation in H. pylori eradication therapy mainly involves two aspects, including pharmacists' pharmaceutical care and patients' medication compliance (Al‐Eidan et al, 2002; Martins et al, 2006; Seko et al, 2019; Sun et al, 2020). On the whole, pharmacists' participation in H. pylori eradication therapy could improve patient compliance, H. pylori eradication rate and patient satisfaction.…”